Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6007 clinical trials
Intravesical Gemcitabine and Docetaxel for BCG na ve Non-muscle Invasive Bladder Cancer

A single-arm, two-stage, open-label, phase 2 study investigating the safety and efficacy of intravesical gemcitabine/docetaxel for bacillus Calmette-Guerin (BCG)-nave patients with non-muscle invasive bladder cancer (NMIBC). All participants will receive an induction course of gemcitabine/docetaxel instillations followed by maintenance instillations if initial efficacy is seen.

docetaxel
bilateral salpingectomy
bilateral oophorectomy
bladder carcinoma
carcinoma in situ
  • 0 views
  • 16 Feb, 2024
  • 1 location
Peer-led Social Media Intervention to Prevent HIV Among Young Men Who Have Sex With Men (YMSM)

The aim of this study is to examine the effect of social media intervention on the use of pre-exposure prophylaxis (PrEP) by young men who have sex with men (YMSM) in the greater New Haven area.

pre exposure prophylaxis
pre-exposure prophylaxis (prep)
pre-exposure prophylaxis
  • 0 views
  • 16 Feb, 2024
  • 2 locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

A commercial liquid biopsy (circulating tumor DNA) NGS test will be provided to study participants free of charge.

stage iv non-small cell lung cancer
metastasis
pembrolizumab
LKB1
measurable disease
  • 0 views
  • 16 Feb, 2024
  • 28 locations
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

Glucose starvation and metformin have synergistic antitumor effects that are mediated through the concomitant inhibition of glycolysis and mitochondrial oxidative phosphorylation. The BREAKFAST trial will evaluate the antitumor activity of combining cyclic fasting-mimicking diet (FMD), which reproduces the in vitro effects of glucose starvation, plus/minus metformin with standard preperative anthracycline-taxane …

primary tumor
bilateral oophorectomy
preoperative chemotherapy
anthracycline
direct bilirubin
  • 0 views
  • 16 Feb, 2024
  • 1 location
Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients

Phase 2 pilot study, which evaluates the safety and efficacy of Lutetium-177-PSMA radioligand therapy in advanced salivary gland cancer patients.

metastasis
measurable disease
gilbert's syndrome
ct scan
salivary gland cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

The purpose of the research is to evaluate whether both chemotherapy and radiotherapy can lead to higher rates of clinical complete response leading to organ preservation in human subjects with cancer. The objective is to learn if this treatment approach may safely be used as an alternative to the standard …

metastasis
chest ct
folfoxiri
serum pregnancy test
adenocarcinoma of rectum
  • 0 views
  • 16 Feb, 2024
  • 1 location
De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer

The goal of this study is to evaluate short course radiation in the post-operative female pelvis after hysterectomy in stage III-IVA endometrial adenocarcinoma patients, or any stage patients with uterine serous or carcinosarcoma histology. The investigators hypothesize that short course pelvic radiation will have an acute and late grade 3-4 …

absolute neutrophil count
pelvic radiation
carcinosarcoma
neutrophil count
endometrial adenocarcinoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

MD is a frequent complication in patients who are diagnosed with advanced cancer.

anhedonia
depressive disorder
sleep disorder
fatigue
psychiatric disorder
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)

This study is a randomized, national multicenter clinical study which is designed to compare the efficacy of the safety and efficacy of treatment every 3 weeks or 6 weeks in (Non-small-cell-cell cancer, NSCLC) subjects without systematic treatment who used Pembrolizumab after 6 cycles of combined chemotherapy estimated with stable efficacy …

  • 0 views
  • 05 Aug, 2020
Niraparib/TTFields in GBM

Evaluating the efficacy and safety of niraparib and Tumor-Treating Fields (TTFields) in recurrent glioblastoma (GBM).

tumor treating fields therapy
karnofsky performance status
glioblastoma multiforme
niraparib
MRI
  • 0 views
  • 16 Feb, 2024
  • 1 location